Ardelyx (ARDX) Operating Leases (2019 - 2026)
Ardelyx (ARDX) reported Operating Leases of $3.2 million for Q1 2026, up 29.22% on a YoY basis from $2.5 million in Q1 2025, and down 36.78% quarter-over-quarter from $5.1 million in Q4 2025.
Ardelyx (ARDX) Operating Leases (2019 - 2026) Analysis & Trends
Ardelyx has reported Operating Leases for 8 years, with the latest figure at $3.2 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases rose 29.22% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (up 29.22% YoY), and the FY2025 full-year result was $5.1 million, up 400.49% from the prior year.
- Operating Leases for Q1 2026 stood at $3.2 million, down from $5.1 million in the prior quarter.
- The five-year high for Operating Leases was $12.4 million in Q1 2022, with the low at $778000.0 in Q1 2024.
- Historically, Operating Leases has averaged $5.5 million across 5 years, with a median of $4.0 million in 2025.
- Annual changes were most pronounced in 2022 — Operating Leases jumped 3024.43% — and 2024, when it plunged 91.17%.
- Ardelyx's Operating Leases stood at $9.7 million in 2022, then plunged by 36.81% to $6.2 million in 2023, then tumbled by 83.39% to $1.0 million in 2024, then surged by 400.49% to $5.1 million in 2025, then slumped by 36.78% to $3.2 million in 2026.
- The last three Operating Leases figures came in at $3.2 million (Q1 2026), $5.1 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.24 Mn |
| Dec 31, 2025 | 5.12 Mn |
| Sep 30, 2025 | 4.04 Mn |
| Jun 30, 2025 | 4.02 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 778,000.00 |
| Dec 31, 2023 | 6.16 Mn |
| Sep 30, 2023 | 7.21 Mn |
| Jun 30, 2023 | 3.75 Mn |
| Mar 31, 2023 | 8.81 Mn |
| Dec 31, 2022 | 9.75 Mn |
| Sep 30, 2022 | 10.67 Mn |
| Jun 30, 2022 | 11.55 Mn |
| Mar 31, 2022 | 12.40 Mn |
| Dec 31, 2021 | 9.75 Mn |
| Sep 30, 2021 | 14.06 Mn |
| Jun 30, 2021 | 14.73 Mn |